We demonstrated that patients with EGPA who experience frequent relapses after initial clinical remission have decreased Treg cell counts; increased percentages of B cells positive for CD80, CD27, or CD95; lower CD19+ B cell counts; and lower serum IgG than do those who maintain remission [12]. This evidence concerns the gene CD80 and eosinophilic granulomatosis with polyangiitis.